Professional Documents
Culture Documents
Djatnika Setiabudi
DEPARTMENT OF PEDIATRICS
HASAN SADIKIN GENERAL HOSPITAL
BANDUNG
Introduction (1)
Introduction (2)
Mortality rate
Indonesia
- 1968 : 41,3 % - 1984 : 3,0 %
- 1998 : 1,9 % - 2003 : + 2,0 %
Queen Sirikit National Institute of Child
Health (Children Hospital) Bangkok :
- 1970 : 10 %
- 1984 :
2 %
- 1990 : 0.2 %
Target of WHO : < 1 %
Clinical spectrum of
Dengue Virus infection
Dengue virus infection
Asymptomatic
Undifferentiated
febrile illness
Symptomatic
Dengue Fever
Without
Hemorrhage
With unusual
Hemorrhage
Shock (-)
Shock (+)
DSS
PATHOGENESIS
1.
2.
3.
4.
IMMUNOPATHOLOGY THEORY
ANTIGEN- ANTIBODY THEORY
ANTIBODY DEPENDENT
ENHANCEMENT (ADE) THEORY
MEDIATOR THEORY
BLEEDING
MANIFESTATION
HEPATOMEGALY
INCREASE
VASCULAR
PERMIABILITY
TROMBOCYTOPENIA
Plasma leakage :
Hemoconcentration
Hipoproteinemia
Pleural effusion
Ascites
Dehydration
Hypovolemia
DIC
G.I. bleeding
Suchitra (1993)
Shock
Anoxia
Death
Acidosis
PATHOPHYSIOLOGY OF DSS
Plasma leakage
Hypovolemia
Circulatory
disturbance
Bleeding
Grade 1
(1)
Grade 2
Grade 1 manifestations +
spontaneous bleeding
Grade 3
(2)
Principles of DSS
management
Early detection
Prompt and adequate fluid
replacement
Closed monitoring
Four
FourCriteria
Criteriafor
forDHF:
DHF:
Fever
Fever
Hemorrhagic
Hemorrhagicmanifestations
manifestations
Excessive
Excessivecapillary
capillary
permeability
permeability
3
100,000/mm
100,000/mm3platelets
platelets
Four
FourCriteria
Criteriafor
forDHF:
DHF:
Fever
Fever
Hemorrhagic
Hemorrhagicmanifestations
manifestations
Excessive
Excessivecapillary
capillary
permeability
permeability
3
100,000/mm
100,000/mm3platelets
platelets
Initial
InitialWarning
WarningSignals:
Signals:
Disappearance
Disappearanceof
offever
fever
Drop
Dropininplatelets
platelets
Increase
Increaseininhematocrit
hematocrit
Four
FourCriteria
Criteriafor
forDHF:
DHF:
Fever
Fever
Hemorrhagic
Hemorrhagicmanifestations
manifestations
Excessive
Excessivecapillary
capillary
permeability
permeability
3
100,000/mm
100,000/mm3platelets
platelets
Initial
InitialWarning
WarningSignals:
Signals:
Disappearance
Disappearanceof
offever
fever
Drop
Dropininplatelets
platelets
Increase
Increaseininhematocrit
hematocrit
AlarmSignals:
Signals:
Alarm
Severeabdominal
abdominalpain
pain
Severe
Prolongedvomiting
vomiting
Prolonged
Abruptchange
changefrom
fromfever
fever
Abrupt
tohypothermia
hypothermia
to
Changeininlevel
levelof
of
Change
consciousness(irritability
(irritability
consciousness
or somnolence)
Four
FourCriteria
Criteriafor
forDHF:
DHF:
Fever
Fever
Hemorrhagic
Hemorrhagicmanifestations
manifestations
Excessive
Excessivecapillary
capillary
permeability
permeability
3
100,000/mm
100,000/mm3platelets
platelets
Initial
InitialWarning
WarningSignals:
Signals:
Disappearance
Disappearanceof
offever
fever
Drop
Dropininplatelets
platelets
Increase
Increaseininhematocrit
hematocrit
AlarmSignals:
Signals:
Alarm
Severeabdominal
abdominalpain
pain
Severe
Prolongedvomiting
vomiting
Prolonged
Abruptchange
changefrom
fromfever
fever
Abrupt
tohypothermia
hypothermia
to
Change
Change
inlevel
level
of
When
in
of
When
Patients
Develop
Patients Develop
consciousness
(irritability
consciousness
(irritability
DSS:
DSS:
to66days
daysafter
afteronset
onsetof
of
33to
or somnolence)
Four
FourCriteria
Criteriafor
forDHF:
DHF:
Fever
Fever
Hemorrhagic
Hemorrhagicmanifestations
manifestations
Excessive
Excessivecapillary
capillary
permeability
permeability
3
100,000/mm
100,000/mm3platelets
platelets
Initial
InitialWarning
WarningSignals:
Signals:
Disappearance
Disappearanceof
offever
fever
Drop
Dropininplatelets
platelets
Increase
Increaseininhematocrit
hematocrit
AlarmSignals:
Signals:
Alarm
Severeabdominal
abdominalpain
pain
Severe
Prolongedvomiting
vomiting
Prolonged
Abruptchange
changefrom
fromfever
fever
Abrupt
tohypothermia
hypothermia
to
Change
Change
inlevel
level
of
When
in
of
When
Patients
Develop
Patients Develop
consciousness
(irritability
consciousness
(irritability
DSS:
DSS:
to66days
daysafter
afteronset
onsetof
of
33to
or somnolence)
Treatment of DSS
Therapetic objectives in the treatment of
hypovolemic shock:
- normalize blood volume
- regulate blood pressure
- stabilize cardiac function
- improve tissue perfusion
- raise oxygen delivery
Treatment of DSS
(1)
- Body-weight measurement
- ABC resuscitation
- Vascular access
- Blood sampling
- Fluid resuscitation
- Urine catheter
Treatment of DSS
(2)
Body-weight measurement
- Important for baseline
- determine the volume of fluid needed
- important for monitoring (overload?)
Treatment of DSS
(3)
ABC resuscitation
- Basic life support
- most important thing : OXYGEN
- Preventing and correcting hypoxemia
- Maintenance O2 saturation 95-100%
Treatment of DSS
(4)
Treatment of DSS
(5)
Fluid resuscitation
- Rapid and aggressive
- increasing preload and cardiac output
- restore effective circulation
- restore oxygen-carrying capacity
- correcting metabolic and electrolyte
disturbance
Treatment of DSS
(6)
Urine Catheter
- monitor diuresis
keep urine output > 1 ml/kgBW/hour
- urinalysis : ! Specific gravity !
SHOCK
IMPROVEMENT
Crystalloid10ml/kgBW/hour
NOIMPROVEMENT
Repeatbolus
Monitoringvitalsign,diuresis
PCV,Thrombocyte
NOIMPROVEMENT
Maintenance
Stabilfor1224hour
Colloid20ml/kgBW/hour
Crystalloid5ml/kgBW/hour
Stabilfor612hour
Crystalloid3ml/kgBW/hour
StopIVfluid
(nomorethan48hour)
IMPROVEMENT
SHOCK
IMPROVEMENT
Crystalloid10ml/kgBW/hour
NOImprovement
Repeatbolus
Monitoringvitalsign,diuresis
PCV,Thrombocyte
NOIMPROVEMENT
IMPROVEMENT
Maintenance
Stabilfor1224hour
Colloid20ml/kgBW/hour
Crystalloid5ml/kgBW/hour
Stabilfor612hour
- IMPROVEMENT
NO
StopIVfluid
(nomorethan48hour)
Nhan NT, Phuong CXT, Kneen R, et al. Clin Inf Dis 2001
Treatment of DIC
- Massive bleeding , Hb / PCV low
Fresh whole blood : 10 20 ml/kgBW
- If NO Blood component transfusion
Thrombocyte : 1 Unit (Bag)/ 5 kgBW
Fresh Frozen Plasma : 10 - 15 ml/ kgBW
Cryoprecipitate ( if fibrinogen < 100 mg/dl)
1 bag / 3 kgBW : infant
1 bag / 6 kgBW in older children
Pearls in management
Early recognition of sign of shock can modify
20%
Suchitra, 2002
Pitfalls in management
Use hypotonic solution and delay to use colloidal
Suchitra, 2002